Using a short vitrectomy probe for pediatric eye surgeries

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and effectiveness of an 18 mm short vitrectomy probe specifically designed for pediatric vitreoretinal surgeries. It addresses the unique challenges faced in pediatric eye surgery, such as the need for greater stability and ease of manipulation during procedures. The study aims to enhance surgeon comfort and reliability when using this shorter probe, which could lead to fewer complications and improved surgical outcomes for children. By focusing on various pediatric retinal diseases, the research seeks to provide insights into the benefits of this innovative surgical tool.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients less than 18 years old
* Need vitrectomy due to various etiologies, including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, congenital cataract, lens dislocation, open-globe injury, vitreous hemorrhage, or other vitreoretinal diseases.

Exclusion Criteria:

* Patients who cannot cooperate fully with detailed ophthalmic examinations.

Where it's running

• Chang Gung Memorial Hospital
  Taoyuan, Taiwan Recruiting

Study contacts

• Study coordinator: Wei-Chi Wu, MD, PhD
• Email: weichi666@gmail.com
• Phone: 886975365848

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Multimodal Eye Data Bank to Explore Inflammation-Related Eye Diseases

  This observational effort collects rich eye-imaging data from people with inflammatory and retinal conditions to see how the front and back of the eye relate and to build a standardized database that could support future AI tools.

  Recruiting Capital Medical University · Beijing · NCT07628946

• Tracking retinal changes over two years in people with moderate to early proliferative diabetic retinopathy

  This project will try to find imaging, functional, and blood markers that show whether retinopathy is getting worse over two years in people with type 2 diabetes and moderate-to-mildly advanced disease.

  Recruiting Association for Innovation and Biomedical Research on Light and Image · Coimbra · NCT07458516

• OCT data collection from healthy and diseased eyes (A10900)

  This project will collect Optical Coherence Tomography (OCT) scans from adults 22 and older who have retinal disease, glaucoma, corneal conditions, or are healthy to build a reference dataset for A10900.

  Recruiting at 3 sites Optos, PLC · Anaheim, California and 3 other locations · NCT07149740

• Choriocapillaris blood flow differences in people with pseudoxanthoma elasticum versus healthy adults

  We will test whether a noninvasive eye scan (OCT angiography) shows reduced choriocapillaris blood flow in adults with pseudoxanthoma elasticum compared with matched healthy adults.

  Recruiting University Hospital, Angers · Angers · NCT07006649

• Sepofarsen injections for LCA10 due to the CEP290 p.Cys998X mutation

  This study will test whether sepofarsen eye injections can improve vision in children and adults with LCA10 caused by the CEP290 c.2991+1655A>G (p.Cys998X) mutation.

  Recruiting at 17 sites Phase 3 Laboratoires Thea · San Francisco, California and 17 other locations · NCT06891443

• Auto-aligning handheld OCT for adult and pediatric retinal imaging

  We will test a new handheld OCT device that automatically aligns to capture retinal images in healthy adults, adult eye patients, and children.

  Recruiting Duke University · Durham, North Carolina · NCT06841575

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.